Vivoryon Therapeutics N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
25 feb 2015 - 13:00
Statutory name
Vivoryon Therapeutics N.V.
Title
Probiodrug to present at European Life Sciences Conferences
Comments
Probiodrug to present at European Life Sciences Conferences
HALLE/SAALE, Germany, 25 February 2015 - Probiodrug AG ("Probiodrug", Euronext: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, announces that Probiodrug's CEO and co-founder, Dr Konrad Glund, is scheduled to present at the following events:
Date last update: 25 April 2026